GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Interest Coverage

Notable Labs (Notable Labs) Interest Coverage : N/A (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Notable Labs's Operating Income for the six months ended in Dec. 2023 was $-14.66 Mil. Notable Labs's Interest Expense for the six months ended in Dec. 2023 was $0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Notable Labs Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Notable Labs's Interest Coverage or its related term are showing as below:


NTBL's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 142.97
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Notable Labs Interest Coverage Historical Data

The historical data trend for Notable Labs's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Notable Labs Interest Coverage Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Interest Coverage
N/A No Debt N/A

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Interest Coverage N/A No Debt N/A

Competitive Comparison of Notable Labs's Interest Coverage

For the Biotechnology subindustry, Notable Labs's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Notable Labs's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Notable Labs's Interest Coverage falls into.



Notable Labs Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Notable Labs's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Notable Labs's Interest Expense was $0.00 Mil. Its Operating Income was $-14.66 Mil. And its Long-Term Debt & Capital Lease Obligation was $1.53 Mil.

GuruFocus does not calculate Notable Labs's interest coverage with the available data.

Notable Labs's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the six months ended in Dec. 2023, Notable Labs's Interest Expense was $0.00 Mil. Its Operating Income was $-14.66 Mil. And its Long-Term Debt & Capital Lease Obligation was $1.53 Mil.

GuruFocus does not calculate Notable Labs's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Notable Labs  (NAS:NTBL) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Notable Labs Interest Coverage Related Terms

Thank you for viewing the detailed overview of Notable Labs's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.